Biomerica, Inc. (BMRA)
NASDAQ: BMRA · Real-Time Price · USD
0.355
-0.017 (-4.57%)
Nov 4, 2024, 4:00 PM EST - Market closed

Biomerica Statistics

Total Valuation

Biomerica has a market cap or net worth of $5.97 million. The enterprise value is $3.86 million.

Market Cap 5.97M
Enterprise Value 3.86M

Important Dates

The last earnings date was Tuesday, October 15, 2024, after market close.

Earnings Date Oct 15, 2024
Ex-Dividend Date n/a

Share Statistics

Biomerica has 16.82 million shares outstanding. The number of shares has increased by 11.52% in one year.

Shares Outstanding 16.82M
Shares Change (YoY) +11.52%
Shares Change (QoQ) n/a
Owned by Insiders (%) 7.22%
Owned by Institutions (%) 15.94%
Float 15.61M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 1.08
Forward PS n/a
PB Ratio 1.12
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 0.70
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 3.00, with a Debt / Equity ratio of 0.13.

Current Ratio 3.00
Quick Ratio 2.03
Debt / Equity 0.13
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -76.48% and return on invested capital (ROIC) is -45.59%.

Return on Equity (ROE) -76.48%
Return on Assets (ROA) -38.54%
Return on Capital (ROIC) -45.59%
Revenue Per Employee $86,078
Profits Per Employee -$96,281
Employee Count 64
Asset Turnover 0.52
Inventory Turnover 2.63

Taxes

In the past 12 months, Biomerica has paid $23,000 in taxes.

Income Tax 23,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -58.72% in the last 52 weeks. The beta is -1.14, so Biomerica's price volatility has been lower than the market average.

Beta (5Y) -1.14
52-Week Price Change -58.72%
50-Day Moving Average 0.34
200-Day Moving Average 0.60
Relative Strength Index (RSI) 55.52
Average Volume (20 Days) 294,546

Short Selling Information

The latest short interest is 373,666, so 2.22% of the outstanding shares have been sold short.

Short Interest 373,666
Short Previous Month 438,946
Short % of Shares Out 2.22%
Short % of Float 2.39%
Short Ratio (days to cover) 5.52

Income Statement

In the last 12 months, Biomerica had revenue of $5.51 million and -$6.16 million in losses. Loss per share was -$0.37.

Revenue 5.51M
Gross Profit 488,000
Operating Income -6.50M
Pretax Income -6.30M
Net Income -6.16M
EBITDA -6.42M
EBIT -6.50M
Loss Per Share -$0.37
Full Income Statement

Balance Sheet

The company has $2.82 million in cash and $707,000 in debt, giving a net cash position of $2.11 million or $0.13 per share.

Cash & Cash Equivalents 2.82M
Total Debt 707,000
Net Cash 2.11M
Net Cash Per Share $0.13
Equity (Book Value) 5.35M
Book Value Per Share 0.32
Working Capital 4.29M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$5.03 million and capital expenditures -$30,000, giving a free cash flow of -$5.06 million.

Operating Cash Flow -5.03M
Capital Expenditures -30,000
Free Cash Flow -5.06M
FCF Per Share -$0.30
Full Cash Flow Statement

Margins

Gross margin is 8.86%, with operating and profit margins of -118.04% and -111.85%.

Gross Margin 8.86%
Operating Margin -118.04%
Pretax Margin -111.44%
Profit Margin -111.85%
EBITDA Margin -116.57%
EBIT Margin -118.04%
FCF Margin -98.18%

Dividends & Yields

Biomerica does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -11.52%
Shareholder Yield -11.52%
Earnings Yield -103.19%
FCF Yield -84.75%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a

Stock Splits

The last stock split was on November 14, 1994. It was a reverse split with a ratio of 0.5:1.

Last Split Date Nov 14, 1994
Split Type Reverse
Split Ratio 0.5:1

Scores

Biomerica has an Altman Z-Score of -7 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -7
Piotroski F-Score 2